Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer’s disease

BACKGROUND: Neuropsychiatric symptoms (NPS) are increasingly recognized as early non-cognitive manifestations in the Alzheimer’s disease (AD) continuum. However, the role of NPS as an early marker of pathophysiological progression in AD remains unclear. Dominantly inherited AD (DIAD) mutation carrie...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Transl Neurodegener
Autori principali: Ng, Kok Pin, Pascoal, Tharick A., Mathotaarachchi, Sulantha, Chan, Yiong Huak, Jiang, Lai, Therriault, Joseph, Benedet, Andrea L., Shin, Monica, Kandiah, Nagaendran, Greenwood, Celia M. T., Rosa-Neto, Pedro, Gauthier, Serge
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2021
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7780680/
https://ncbi.nlm.nih.gov/pubmed/33390174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40035-020-00225-y
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi